Jessica Fung analyst JPMORGAN

Currently out of the existing stock ratings of Jessica Fung, 5 are a HOLD (62.5%), 3 are a BUY (37.5%).

Jessica Fung

Work Performance Price Targets & Ratings Chart

Analyst Jessica Fung works at JPMORGAN with a stock forecast success ratio of 66.67% fulfilled within 129.33 days on average.

Jessica Fung’s has documented 16 price targets and ratings displayed on 3 stocks. The coverage is on Basic Materials, Healthcare sectors.

Most recent stock forecast was given on ALNY, Alnylam Pharmaceuticals at 01-Feb-2024.

Wall Street Analyst Jessica Fung

Analyst best performing recommendations are on ALNY (ALNYLAM PHARMACEUTICALS).
The best stock recommendation documented was for ALNY (ALNYLAM PHARMACEUTICALS) at 3/3/2023. The price target of $196 was fulfilled within 4 days with a profit of $6.58 (3.25%) receiving and performance score of 8.12.

Average potential price target upside

PAAS Pan American Silver Corp. UTHR United Therapeutics ALNY Alnylam Pharmaceuticals

Analyst name

Rating

Current price target

Potential distance

Previous price target

Date

Price targets met ratio

Average potential upside

Average Time (Days) For PT To Be Met

Performance score

Buy

20

$1.38 (7.41%)

19.5

20 days ago

1/2 (50%)

$1.93 (10.68%)

48

Buy

18

$-0.62 (-3.33%)

19.5

3 months 10 days ago

5/7 (71.43%)

$4.39 (32.26%)

89

Buy

22

$3.38 (18.15%)

27

3 months 10 days ago

3/7 (42.86%)

$8.39 (61.65%)

143

Buy

20

$1.38 (7.41%)

22

3 months 20 days ago

1/5 (20%)

$4.69 (30.63%)

492

Buy

20

$1.38 (7.41%)

22

5 months 15 days ago

0/3 (0%)

$7.06 (54.56%)

Show more analysts

To gain access for the analyst/ stock price target chart please use a computer

Which stock is Jessica Fung is most bullish on?

Potential upside of $57 has been obtained for UTHR (UNITED THERAPEUTICS)

Which stock is Jessica Fung is most reserved on?

Potential downside of $26.2 has been obtained for ALNY (ALNYLAM PHARMACEUTICALS)

What Year was the first public recommendation made by Jessica Fung?

On 2015

To continue looking at which analysts cover the stock please register to the basic or advanced membership

What is AnaChart?